/Companies

ModernVivo

1 known investors

Find your way into ModernVivo

Sign up to see every warm intro you have to ModernVivo

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the ModernVivo team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

ModernVivo is a software platform that automates literature review and analysis for in vivo study design in pharmaceutical research and preclinical development. It serves pharmaceutical companies, contract research organizations, academic labs, and institutional animal care committees by extracting study parameters from scientific literature to accelerate drug discovery timelines.

Founders & leadership

ILIan Levine
Ian LevineCo-Founder and CEOCo-founder and CEO of ModernVivo, which develops software to automate literature analysis for preclinical animal study design in pharmaceutical research.

Investors · 1

Frequently asked questions

What does ModernVivo do?
ModernVivo is a software platform that automates literature review and analysis for in vivo study design in pharmaceutical research and preclinical development. It serves pharmaceutical companies, contract research organizations, academic labs, and institutional animal care committees by extracting study parameters from scientific literature to accelerate drug discovery timelines.
Who founded ModernVivo?
ModernVivo was founded by Ian Levine.
Who are ModernVivo's investors?
ModernVivo's investors include Debiopharm Innovation Fund.